Author

Carolina Lemos

Universidade do PortoORCID 0000-0001-9803-9584Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Andreia DiasiD· 2 shared Mariana SantosiD· 2 shared Alda SousaiD· 1 shared Ana Isabel SeixasiD· 1 shared Bruno CavadasiD· 1 shared Carla OliveiraiD· 1 shared Carla PereiraiD· 1 shared Daniel FerreiraiD· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Andreia DiasORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintJan 22, 2026

Neuropeptide S as a potential risk locus for migraine in the Portuguese population

Rodrigo C. De Marco, Kevin Pucci, Mariana Santos…·Andreia Dias

The paper conducts a GWAS in the Portuguese population to identify migraine risk loci, finding a novel association with the NPS gene and highlighting potential therapeutic targets.

1 citation

humanGWAS summary statistics

𝕏 PostBluesky

NeuroscienceCell ReportsPeer-reviewedOct 1, 2025

Rac1 inhibition prevents axonal cytoskeleton dysfunction in Transthyretin Amyloid Polyneuropathy

Joana Magalhães, Vítor Pacheco Dias, Jessica Eira…·Márcia A. Liz

This study shows that Rac1 inhibition prevents cytoskeletal dysfunction in ATTRv-PN by rescuing axonal defects in mice and supporting its therapeutic potential in patients.

3 citations

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 30, 2018

CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients

Carla Pereira, Daniel Ferreira, Carolina Lemos…·Carla Oliveira

This study identifies CD44v6 expression as a predictor of therapy response and poor prognosis in gastric cancer patients, showing higher expression correlates with worse outcomes and benefit from chemotherapy.

DOI 10.1101/468934

humanproteomics

𝕏 PostBluesky